Raghuram Selvaraju is Chairman of RELIEF THERAPEUTICS Holding AG and Managing Director & Senior Healthcare Analyst at H. C. Wainwright & Co. LLC. Dr. Selvaraju is also Managing Director-Equity Research at H C Wainwright & Co.

In his past career he held the position of Analyst at Serono Pharmaceutical Research Institute, Managing Director & Associate Analyst at Rodman & Renshaw LLC (Old), Senior Biotechnology Analyst at Morgan Joseph TriArtisan LLC, MD & Head-Health Care Equity Research at Aegis Capital Corp., Senior Research Analyst at Noble Capital Markets, Inc., Senior Analyst at Hapoalim Securities USA, Inc. and Managing Director & Senior Healthcare Analyst at MLV & Co. LLC.

Dr. Selvaraju received an undergraduate degree from Carnegie Mellon University, a doctorate and a graduate degree from the University of Geneva and an MBA from Cornell University.